Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine

In 2002 a Meningococcal serogroup C (MenC) conjugate vaccine, with tetanus toxoid as carrier protein, was introduced in the Netherlands as a single-dose at 14 months of age. A catch-up campaign was performed targeting all individuals aged 14 months to 18 years. We determined the MenC-specific immuni...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2010-08, Vol.5 (8), p.e12144-e12144
Hauptverfasser:	de Voer, Richarda M, Mollema, Liesbeth, Schepp, Rutger M, de Greeff, Sabine C, van Gageldonk, Pieter G M, de Melker, Hester E, Sanders, Elisabeth A M, Berbers, Guy A M, van der Klis, Fiona R M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adolescents Adult Adults Age Aged Aged, 80 and over Antibodies Antibody Specificity Bacillus Banks (Finance) Child Child, Preschool Children Cohort Studies Epidemiology Female Haemophilus influenzae Health risks Humans Immunity Immunization Immunization Programs Immunoglobulin G Immunoglobulins Immunology Immunology/Immune Response Immunology/Immunity to Infections Infant Infant, Newborn Infants Infectious diseases Infectious Diseases/Bacterial Infections Infectious Diseases/Infectious Diseases of the Nervous System Laboratories Male Meningitis Meningococcal Vaccines - immunology Middle Aged Music education Neisseria meningitidis Neisseria meningitidis, Serogroup C - immunology Netherlands Polysaccharides - immunology Population Public health Seroepidemiologic Studies Serology Target marketing Teenagers Tetanus Tetanus Toxoid - immunology Vaccination Vaccines Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!